BlackRock Fund Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

BlackRock Fund Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.61M	Sell	446,443 -167,255	-27%	-$1.13M	﹤0.01%	3110
2016 Q3	$4.04M	Buy	613,698 +47,586	+8%	+$377K	﹤0.01%	2939
2016 Q2	$5.25M	Buy	566,112 +209,054	+59%	+$1.99M	﹤0.01%	2774
2016 Q1	$3.85M	Buy	357,058 +20,831	+6%	+$220K	﹤0.01%	2872
2015 Q4	$4.82M	Buy	336,227 +191,513	+132%	+$2.89M	﹤0.01%	2855
2015 Q3	$3.04M	Buy	+144,714	New	+$3.19M	﹤0.01%	3015

Other funds holding NEOS

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock Fund Advisors's NEOS Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Neos Therapeutics, Inc (NEOS) stake by 27% in Q4 2016, selling an estimated $1.13M and leaving 446,443 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3110.

BlackRock Fund Advisors first reported a position in NEOS in Q3 2015 and has held it in 6 quarters since. The position peaked at $5.25M in Q2 2016. 52 funds tracked by Wall St. Rank hold NEOS as of Q4 2016.

BlackRock Fund Advisors held 446,443 shares of Neos Therapeutics, Inc worth $2.61M as of Q4 2016.
BlackRock Fund Advisors sold 167,255 Neos Therapeutics, Inc shares in Q4 2016, an estimated $1.13M.
Neos Therapeutics, Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3110 holding.
BlackRock Fund Advisors first reported a position in Neos Therapeutics, Inc in Q3 2015 and has held it in 6 quarters since.
BlackRock Fund Advisors's Neos Therapeutics, Inc position peaked at $5.25M in Q2 2016.
52 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.